Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (21-30 of 320) with videos related to

Pageof 32
Sort By:
BMC Psychology|August 7, 2021
Psychological reaction to Covid-19 of Italian patients with IBDMariarosaria Savarese, Greta Castellini, Salvatore Leone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practiceAlessandro Armuzzi, Yoram Bouhnik, Fraser Cummings, et al.
International Journal of Environmental Research and Public Health|November 7, 2020
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI SurveyMatteo Ruggeri, Carlo Drago, Chiara Cadeddu, et al.
European Journal of Gastroenterology & Hepatology|September 30, 2009
Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an updateVeruscka Leso, Lorenzo Leggio, Alessandro Armuzzi, et al.
Drug, Healthcare and Patient Safety|February 20, 2016
Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisDaniela Pugliese, Carla Felice, Rosario Landi, et al.
Journal of Clinical Medicine|March 6, 2021
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel DiseasesGiuseppe Privitera, Daniela Pugliese, Gian Ludovico Rapaccini, et al.
Journal of Crohn'S & Colitis|April 28, 2015
Clinical trials in ulcerative colitis: a historical perspectivePieter Hindryckx, Filip Baert, Ailsa Hart, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2020
Biosimilars: The viewpoint of Italian patients with inflammatory bowel diseaseFabio Salvatore Macaluso, Salvatore Leone, Enrica Previtali, et al.
Journal of Crohn'S & Colitis|May 21, 2014
Clinical trials in luminal Crohn's disease: a historical perspectivePieter Hindryckx, Filip Baert, Ailsa Hart, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2026
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?Virginia Solitano, Vipul Jairath, Fernando Magro, et al.
Pageof 32

Showing results (21-30 of 320) with videos related to

Sort By:
Pageof 32
BMC Psychology|August 7, 2021
Psychological reaction to Covid-19 of Italian patients with IBDMariarosaria Savarese, Greta Castellini, Salvatore Leone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2020
Enhancing treatment success in inflammatory bowel disease: Optimising the use of anti-TNF agents and utilising their biosimilars in clinical practiceAlessandro Armuzzi, Yoram Bouhnik, Fraser Cummings, et al.
International Journal of Environmental Research and Public Health|November 7, 2020
The Determinants of Out-of-Pocket Expenditure in IBD Italian Patients. Results from the AMICI SurveyMatteo Ruggeri, Carlo Drago, Chiara Cadeddu, et al.
European Journal of Gastroenterology & Hepatology|September 30, 2009
Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an updateVeruscka Leso, Lorenzo Leggio, Alessandro Armuzzi, et al.
Drug, Healthcare and Patient Safety|February 20, 2016
Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisDaniela Pugliese, Carla Felice, Rosario Landi, et al.
Journal of Clinical Medicine|March 6, 2021
Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel DiseasesGiuseppe Privitera, Daniela Pugliese, Gian Ludovico Rapaccini, et al.
Journal of Crohn'S & Colitis|April 28, 2015
Clinical trials in ulcerative colitis: a historical perspectivePieter Hindryckx, Filip Baert, Ailsa Hart, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2020
Biosimilars: The viewpoint of Italian patients with inflammatory bowel diseaseFabio Salvatore Macaluso, Salvatore Leone, Enrica Previtali, et al.
Journal of Crohn'S & Colitis|May 21, 2014
Clinical trials in luminal Crohn's disease: a historical perspectivePieter Hindryckx, Filip Baert, Ailsa Hart, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2026
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?Virginia Solitano, Vipul Jairath, Fernando Magro, et al.
Pageof 32